Evidence map›Paper›PMID 34047179›Full record

ArticleHaematologica2021

Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with

Katrin Teich, Julia Krzykalla, Silke Kapp-Schwoerer, Verena I Gaidzik, Richard F Schlenk, Peter Paschka, Daniela Weber, Walter Fiedler, Michael W M Kühn, Thomas Schroeder and 9 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. No Evidence thatDisease markers · 2022
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 1 country.

Katrin TeichDepartment of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover.
Julia KrzykallaDivision of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg.
Silke Kapp-SchwoererDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Verena I GaidzikDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Richard F SchlenkNationales Centrum für Tumorerkrankungen Trial Center, National Center of Tumor Diseases, German Cancer Research Center, Heidelberg; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg.
Peter PaschkaDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Daniela WeberDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Walter FiedlerDepartment of Internal Medicine II, University Medical Center Hamburg-Eppendorf, Hamburg.
Michael W M KühnDepartment of Hematology, Medical Oncology and Pneumology, University Medical Center Mainz, Mainz.
Thomas SchroederDepartment of Hematology, Oncology, and Clinical Immunology, University of Düsseldorf, Medical Faculty, Düsseldorf.
Karin MayerInternal Medicine III, University Hospital of Bonn, Bonn.
Michael LübbertKlinik für Innere Medizin I, Universitätsklinikum Freiburg, Faculty of Medicine, Freiburg.
Dhanya RamachandranDepartment Molecular Gynecology, Hannover Medical School, Hannover.
Axel BennerDivision of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg.
Arnold GanserDepartment of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover.
Hartmut DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Michael HeuserDepartment of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover.
Konstanze DöhnerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm.
Felicitas TholDepartment of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover.
University Hospital Ulm · DEMedizinische Hochschule Hannover · DEGerman Cancer Research Center · DEHeidelberg University · DEHeinrich Heine University Düsseldorf · DEUniversity Hospital Bonn · DEUniversity Medical Center Freiburg · DEUniversity Medical Center Hamburg-Eppendorf · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcutePolymorphism, Single NucleotideAminoglycosidesGemtuzumabHumansSialic Acid Binding Ig-like Lectin 3AminoglycosidesGemtuzumabSialic Acid Binding Ig-like Lectin 3

Identifiers

PMID34047179
PMCPMC8561276
OpenAlexW3165524779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.